Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

Share Price is delayed by 15 minutes
Get Live Data
2,340.00    1.00 (0.04%)
Bid:
2,342.00
Ask:
2,344.00
Spread: 2.00 (0.085%)
Market Cap: £3.91b
WTB Live PriceLast checked at - London Stock Exchange

Intraday Whitbread Share Chart

Acquisition in Germany

23 Sep 2019 12:50

RNS Number : 3160N
Whitbread PLC
23 September 2019
 

Acquisition in Germany

23 September 2019

Whitbread announces its second hotel portfolio acquisition in Germany

Whitbread PLC today announces the acquisition of a portfolio of three independent hotels in Germany, from a private individual operating under the brand "Acomhotel". This is Whitbread's second acquisition in Germany as part of a long-term investment plan in a highly attractive market. The acquisition consideration will not be disclosed and Whitbread's return on capital from the acquisition is expected to be above its weighted-average cost of capital.

The portfolio consists of two leasehold hotels that are open and trading, in Nuremburg and Munich, with the right to purchase the freehold in seven and 13 years respectively. A further leasehold hotel is under construction, in Stuttgart. The three locations together comprise 482 rooms.

All three hotels are in strong locations in German tier one cities, which match Whitbread's network planning targets. They are readily convertible to the Premier Inn format with similar room sizes and comparable ground floor space. Whitbread believes that the conversion to Premier Inn will significantly enhance the existing guest experience.

The hotels will continue to trade under the current "Acomhotel" brand until refurbishment work is completed. Once converted, the hotels will be relaunched as Premier Inn hotels, which is expected to be in early 2020.

Mark Anderson, Whitbread PLC Managing Director Property & International, commented:

"Today's announcement marks another important step in our ambitious growth plan for Germany, as part of our strategic priority to focus on our strengths to grow internationally. We have accelerated our investment in Germany through a mix of organic expansion, supported by focused and ongoing M&A activity. We are building a strong counterparty reputation in Germany in freehold and leasehold property transactions, as well as facilitating exit for independent operators. We look forward to welcoming the Acomhotel team and providing even more attractive Premier Inn hotels for domestic German travellers."

Germany market structure

The German hotel market is around 30% larger than the UK and is highly fragmented with 74% of market share held by smaller independents. The high degree of domestic business travel also makes the German market extremely attractive for the Premier Inn short-stay, domestic traveller focused proposition. Through addition of new high-quality capacity offered to customers at attractive prices, Premier Inn is expected to win market share from independent competitors and develop a successful business of scale of the medium to long-term.

German portfolio overview

Premier Inn currently has three hotels open in Germany, all of which are performing in line with our expectations; one in Frankfurt, one in Hamburg and one Munich. A further 40 hotels are now in the committed pipeline across 16 key cities in Germany:

 

Organic

To be acquired

Total

Open and trading

3 hotels (590 rooms)

17 hotels (2,770 rooms)

20 hotels (3,360 rooms)

Committed pipeline

18 hotels (3,690 rooms)

5 hotels (820 rooms)

23 hotels (4,510 rooms)

Total

21 hotels (4,280 rooms)

22 hotels (3,590 rooms)

43 hotels (7,870 rooms)

 

For more information please contact:

Investor queries

Matt Johnson, Whitbread PLC | matt.johnson@whitbread.com | +44 (0) 7848 146 761

Ann Hyams, Whitbread PLC | ann.hyams@whitbread.com | +44 (0) 7796 709 087

Anastasia Pittas, Whitbread PLC | anastasia.pittas@whitbread.com | +44 (0) 7704 537 499

Media queries

Matt Johnson, Whitbread PLC | matt.johnson@whitbread.com | +44 (0) 7848 146 761

David Allchurch / Jessica Reid, Tulchan Communications | +44 (0) 20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQFXLFLKKFZBBD
Date   Source Headline
1st Jun 20269:22 amRNSTotal Voting Rights
29th May 202612:38 pmRNSHolding(s) in Company
22nd May 20265:02 pmRNSDirector/PDMR Shareholding
13th May 20264:46 pmRNSAnnual Financial Report
12th May 20267:34 amRNSDirector Declaration
11th May 20264:40 pmRNSDirector/PDMR Shareholding
8th May 20262:51 pmRNSDirector/PDMR Shareholding
8th May 20262:34 pmRNSHolding(s) in Company
1st May 20269:22 amRNSTotal Voting Rights
30th Apr 20267:02 amRNSOutcome of Business Review
30th Apr 20267:00 amRNSPreliminary Results Announcement
24th Apr 202611:25 amRNSHolding(s) in Company
1st Apr 20269:18 amRNSTotal Voting Rights
2nd Mar 20269:11 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSCORRECTION: Transaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20262:47 pmRNSDirector/PDMR Shareholding
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 202610:34 amRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:37 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.